Improved immunogenicity of a core-coated tetanus toxoid delivery system

By Tobo M.   Schwendeman S.P.   Guo Y.   McIver J.   Langer R.   Alonso M.J.  

Vaccine, Vol. 18, Iss. 7, 1999-11 ,pp. : 618-622

Elsevier

Access to resources Recommend Favorite

Adverse event reporting rates following tetanus-diphtheria and tetanus toxoid vaccinations: data from the Vaccine Adverse Event Reporting System (VAERS), 1991-1997

By Lloyd J.C.   Haber P.   Mootrey G.T.   Braun M.M.   Rhodes P.H.   Chen R.T.   VAERS Working Group  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3746-3750

Elsevier

Access to resources Recommend Favorite

Long-term high immune response to diphtheria toxoid in rodents with diphtheria toxoid conjugated to dextran as a single contact point delivery system

By Diwan M.   Misra A.   Khar R.K.   Talwar G.P.  

Vaccine, Vol. 15, Iss. 17, 1997-12 ,pp. : 1867-1871

Elsevier

Access to resources Recommend Favorite

Controlled release microparticles as a single dose diphtheria toxoid vaccine: immunogenecity in small animal models

By Singh M.   Li X.-M.   Hanying W.   McGee J.P.   Zamb T.   Koff W.   Chang Y.W.   O'Hagan D.T.  

Vaccine, Vol. 16, Iss. 4, 1998-02 ,pp. : 346-352

Elsevier

Access to resources Recommend Favorite

Immunogenicity and reactogenicity of a single dose of a diphtheria-tetanus-acellular pertussis component vaccine (DTaP) compared to a diphtheria-tetanus toxoid (Td) and a diphtheria toxoid vaccine (d) in adults

By Bartels I.   Jungert J.   Lugauer S.   Stehr K.   Heininger U.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3137-3145

Elsevier

Access to resources Recommend Favorite